Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 458 entries
Sorted by: Best Match Show Resources per page
Patient engagement with surgical site infection prevention: an expert panel perspective.

Antimicrobial resistance and infection control

Tartari E, Weterings V, Gastmeier P, Rodríguez Baño J, Widmer A, Kluytmans J, Voss A.
PMID: 28507731
Antimicrob Resist Infect Control. 2017 May 12;6:45. doi: 10.1186/s13756-017-0202-3. eCollection 2017.

Despite remarkable developments in the use of surgical techniques, ergonomic advancements in the operating room, and implementation of bundles, surgical site infections (SSIs) remain a substantial burden, associated with increased morbidity, mortality and healthcare costs. National and international recommendations...

Cite
Tartari E, Weterings V, Gastmeier P, et al. Patient engagement with surgical site infection prevention: an expert panel perspective. Antimicrob Resist Infect Control. 2017;6:45doi: 10.1186/s13756-017-0202-3.
Tartari, E., Weterings, V., Gastmeier, P., Rodríguez Baño, J., Widmer, A., Kluytmans, J., & Voss, A. (2017). Patient engagement with surgical site infection prevention: an expert panel perspective. Antimicrobial resistance and infection control, 645. https://doi.org/10.1186/s13756-017-0202-3
Tartari, E, et al. "Patient engagement with surgical site infection prevention: an expert panel perspective." Antimicrobial resistance and infection control vol. 6 (2017): 45. doi: https://doi.org/10.1186/s13756-017-0202-3
Tartari E, Weterings V, Gastmeier P, Rodríguez Baño J, Widmer A, Kluytmans J, Voss A. Patient engagement with surgical site infection prevention: an expert panel perspective. Antimicrob Resist Infect Control. 2017 May 12;6:45. doi: 10.1186/s13756-017-0202-3. eCollection 2017. PMID: 28507731; PMCID: PMC5427557.
Copy Download .nbib Format: NLM
Of means and ends: The financialization and regulation of health care.

The Linacre quarterly

Widmer A.
PMID: 28392588
Linacre Q. 2016 Nov;83(4):382-386. doi: 10.1080/00243639.2016.1248168.

Health care is at a critical stage: doctors and patients, the central protagonists in this field, are less and less satisfied with the outcomes. Much of the debate about health care has focused on the choice between large public...

Cite
Widmer A. Of means and ends: The financialization and regulation of health care. Linacre Q. 2016;83(4):382-386doi: 10.1080/00243639.2016.1248168.
Widmer, A. (2016). Of means and ends: The financialization and regulation of health care. The Linacre quarterly, 83(4), 382-386. https://doi.org/10.1080/00243639.2016.1248168
Widmer, Andreas. "Of means and ends: The financialization and regulation of health care." The Linacre quarterly vol. 83,4 (2016): 382-386. doi: https://doi.org/10.1080/00243639.2016.1248168
Widmer A. Of means and ends: The financialization and regulation of health care. Linacre Q. 2016 Nov;83(4):382-386. doi: 10.1080/00243639.2016.1248168. PMID: 28392588; PMCID: PMC5375598.
Copy Download .nbib Format: NLM
Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in China.

Frontiers in microbiology

Zhu K, Hölzel CS, Cui Y, Mayer R, Wang Y, Dietrich R, Didier A, Bassitta R, Märtlbauer E, Ding S.
PMID: 27242738
Front Microbiol. 2016 May 23;7:718. doi: 10.3389/fmicb.2016.00718. eCollection 2016.

Bacillus cereus is an important cause of foodborne infectious disease and food poisoning. However, B. cereus has also been used as a probiotic in human medicine and livestock production, with low standards of safety assessment. In this study, we...

Cite
Zhu K, Hölzel CS, Cui Y, et al. Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in China. Front Microbiol. 2016;7:718doi: 10.3389/fmicb.2016.00718.
Zhu, K., Hölzel, C. S., Cui, Y., Mayer, R., Wang, Y., Dietrich, R., Didier, A., Bassitta, R., Märtlbauer, E., & Ding, S. (2016). Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in China. Frontiers in microbiology, 7718. https://doi.org/10.3389/fmicb.2016.00718
Zhu, Kui, et al. "Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in China." Frontiers in microbiology vol. 7 (2016): 718. doi: https://doi.org/10.3389/fmicb.2016.00718
Zhu K, Hölzel CS, Cui Y, Mayer R, Wang Y, Dietrich R, Didier A, Bassitta R, Märtlbauer E, Ding S. Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in China. Front Microbiol. 2016 May 23;7:718. doi: 10.3389/fmicb.2016.00718. eCollection 2016. PMID: 27242738; PMCID: PMC4876114.
Copy Download .nbib Format: NLM
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application.

Scientia pharmaceutica

Hendrayana T, Wilmer A, Kurth V, Schmidt-Wolf IG, Jaehde U.
PMID: 28264440
Sci Pharm. 2017 Feb 27;85(1). doi: 10.3390/scipharm85010008.

Most anticancer agents exhibit a narrow therapeutic index, i.e., a small change in plasma concentrations can lead to a less efficacious treatment or an unacceptable degree of toxicity. This study aimed at providing health professionals with a feasible and...

Cite
Hendrayana T, Wilmer A, Kurth V, et al. Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Sci Pharm. 2017;85(1)doi: 10.3390/scipharm85010008.
Hendrayana, T., Wilmer, A., Kurth, V., Schmidt-Wolf, I. G., & Jaehde, U. (2017). Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Scientia pharmaceutica, 85(1), . https://doi.org/10.3390/scipharm85010008
Hendrayana, Tomi, et al. "Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application." Scientia pharmaceutica vol. 85,1 (2017). doi: https://doi.org/10.3390/scipharm85010008
Hendrayana T, Wilmer A, Kurth V, Schmidt-Wolf IG, Jaehde U. Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Sci Pharm. 2017 Feb 27;85(1). doi: 10.3390/scipharm85010008. PMID: 28264440; PMCID: PMC5388145.
Copy Download .nbib Format: NLM
Bottom-Up Synthesis of Metalated Carbyne.

Journal of the American Chemical Society

Sun Q, Cai L, Wang S, Widmer R, Ju H, Zhu J, Li L, He Y, Ruffieux P, Fasel R, Xu W.
PMID: 26780188
J Am Chem Soc. 2016 Feb 03;138(4):1106-9. doi: 10.1021/jacs.5b10725. Epub 2016 Jan 20.

Because of stability issues, carbyne, a one-dimensional chain of carbon atoms, has been much less investigated than other recent carbon allotropes such as graphene. Beyond that, metalation of such a linear carbon nanostructure with regularly distributed metal atoms is...

Cite
Sun Q, Cai L, Wang S, et al. Bottom-Up Synthesis of Metalated Carbyne. J Am Chem Soc. 2016;138(4):1106-9doi: 10.1021/jacs.5b10725.
Sun, Q., Cai, L., Wang, S., Widmer, R., Ju, H., Zhu, J., Li, L., He, Y., Ruffieux, P., Fasel, R., & Xu, W. (2016). Bottom-Up Synthesis of Metalated Carbyne. Journal of the American Chemical Society, 138(4), 1106-9. https://doi.org/10.1021/jacs.5b10725
Sun, Qiang, et al. "Bottom-Up Synthesis of Metalated Carbyne." Journal of the American Chemical Society vol. 138,4 (2016): 1106-9. doi: https://doi.org/10.1021/jacs.5b10725
Sun Q, Cai L, Wang S, Widmer R, Ju H, Zhu J, Li L, He Y, Ruffieux P, Fasel R, Xu W. Bottom-Up Synthesis of Metalated Carbyne. J Am Chem Soc. 2016 Feb 03;138(4):1106-9. doi: 10.1021/jacs.5b10725. Epub 2016 Jan 20. PMID: 26780188.
Copy Download .nbib Format: NLM
Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti.

Journal of AIDS & clinical research

Louis FJ, Osborne AJ, Elias VJ, Buteau J, Boncy J, Elong A, Dismer A, Sasi V, Domercant JW, Lauture D, Balajee SA, Marston BJ.
PMID: 26900489
J AIDS Clin Res. 2015;6(8). doi: 10.4172/2155-6113.1000488. Epub 2015 Jun 26.

OBJECTIVES: Regular and quality CD4 testing is essential to monitor disease progression in people living with HIV. In Haiti, most laboratories have limited infrastructure and financial resources and have relied on manual laboratory techniques. We report the successful implementation...

Cite
Louis FJ, Osborne AJ, Elias VJ, et al. Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti. J AIDS Clin Res. 2015;6(8)doi: 10.4172/2155-6113.1000488.
Louis, F. J., Osborne, A. J., Elias, V. J., Buteau, J., Boncy, J., Elong, A., Dismer, A., Sasi, V., Domercant, J. W., Lauture, D., Balajee, S. A., & Marston, B. J. (2015). Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti. Journal of AIDS & clinical research, 6(8), . https://doi.org/10.4172/2155-6113.1000488
Louis, Frantz Jean, et al. "Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti." Journal of AIDS & clinical research vol. 6,8 (2015). doi: https://doi.org/10.4172/2155-6113.1000488
Louis FJ, Osborne AJ, Elias VJ, Buteau J, Boncy J, Elong A, Dismer A, Sasi V, Domercant JW, Lauture D, Balajee SA, Marston BJ. Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti. J AIDS Clin Res. 2015;6(8). doi: 10.4172/2155-6113.1000488. Epub 2015 Jun 26. PMID: 26900489; PMCID: PMC4756652.
Copy Download .nbib Format: NLM
Reply to Werth et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer A, Schmitt SK, Hendershot E, Holtom P, Huddleston P, Petermann G, Osmon D.
PMID: 27161779
Clin Infect Dis. 2016 Jul 15;63(2):282. doi: 10.1093/cid/ciw287. Epub 2016 May 08.

No abstract available.

Cite
Berbari EF, Kanj SS, Kowalski TJ, et al. Reply to Werth et al. Clin Infect Dis. 2016;63(2):282doi: 10.1093/cid/ciw287.
Berbari, E. F., Kanj, S. S., Kowalski, T. J., Darouiche, R. O., Widmer, A., Schmitt, S. K., Hendershot, E., Holtom, P., Huddleston, P., Petermann, G., & Osmon, D. (2016). Reply to Werth et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63(2), 282. https://doi.org/10.1093/cid/ciw287
Berbari, Elie F, et al. "Reply to Werth et al." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 63,2 (2016): 282. doi: https://doi.org/10.1093/cid/ciw287
Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer A, Schmitt SK, Hendershot E, Holtom P, Huddleston P, Petermann G, Osmon D. Reply to Werth et al. Clin Infect Dis. 2016 Jul 15;63(2):282. doi: 10.1093/cid/ciw287. Epub 2016 May 08. PMID: 27161779.
Copy Download .nbib Format: NLM
Exciton Diffusion Length and Charge Extraction Yield in Organic Bilayer Solar Cells.

Advanced materials (Deerfield Beach, Fla.)

Siegmund B, Sajjad MT, Widmer J, Ray D, Koerner C, Riede M, Leo K, Samuel ID, Vandewal K.
PMID: 28145601
Adv Mater. 2017 Mar;29(12). doi: 10.1002/adma.201604424. Epub 2017 Feb 01.

A method for resolving the diffusion length of excitons and the extraction yield of charge carriers is presented based on the performance of organic bilayer solar cells and careful modeling. The technique uses a simultaneous variation of the absorber...

Cite
Siegmund B, Sajjad MT, Widmer J, et al. Exciton Diffusion Length and Charge Extraction Yield in Organic Bilayer Solar Cells. Adv Mater. 2017;29(12)doi: 10.1002/adma.201604424.
Siegmund, B., Sajjad, M. T., Widmer, J., Ray, D., Koerner, C., Riede, M., Leo, K., Samuel, I. D., & Vandewal, K. (2017). Exciton Diffusion Length and Charge Extraction Yield in Organic Bilayer Solar Cells. Advanced materials (Deerfield Beach, Fla.), 29(12), . https://doi.org/10.1002/adma.201604424
Siegmund, Bernhard, et al. "Exciton Diffusion Length and Charge Extraction Yield in Organic Bilayer Solar Cells." Advanced materials (Deerfield Beach, Fla.) vol. 29,12 (2017). doi: https://doi.org/10.1002/adma.201604424
Siegmund B, Sajjad MT, Widmer J, Ray D, Koerner C, Riede M, Leo K, Samuel ID, Vandewal K. Exciton Diffusion Length and Charge Extraction Yield in Organic Bilayer Solar Cells. Adv Mater. 2017 Mar;29(12). doi: 10.1002/adma.201604424. Epub 2017 Feb 01. PMID: 28145601.
Copy Download .nbib Format: NLM
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.

EMBO molecular medicine

Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Gemmy Cheung CM, Bo Tun SB, Wey YS, Iwata D, Dostalek M, Moelleken J, Stubenrauch KG, Nogoceke E, Widmer G, Strassburger P, Koss MJ, Klein C, Shima DT, Hartmann G.
PMID: 28533211
EMBO Mol Med. 2017 Jul;9(7):985. doi: 10.15252/emmm.201707895.

No abstract available.

Cite
Regula JT, Lundh von Leithner P, Foxton R, et al. Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO Mol Med. 2017;9(7):985doi: 10.15252/emmm.201707895.
Regula, J. T., Lundh von Leithner, P., Foxton, R., Barathi, V. A., Gemmy Cheung, C. M., Bo Tun, S. B., Wey, Y. S., Iwata, D., Dostalek, M., Moelleken, J., Stubenrauch, K. G., Nogoceke, E., Widmer, G., Strassburger, P., Koss, M. J., Klein, C., Shima, D. T., & Hartmann, G. (2017). Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO molecular medicine, 9(7), 985. https://doi.org/10.15252/emmm.201707895
Regula, Jörg T, et al. "Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases." EMBO molecular medicine vol. 9,7 (2017): 985. doi: https://doi.org/10.15252/emmm.201707895
Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Gemmy Cheung CM, Bo Tun SB, Wey YS, Iwata D, Dostalek M, Moelleken J, Stubenrauch KG, Nogoceke E, Widmer G, Strassburger P, Koss MJ, Klein C, Shima DT, Hartmann G. Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO Mol Med. 2017 Jul;9(7):985. doi: 10.15252/emmm.201707895. PMID: 28533211; PMCID: PMC5494529.
Copy Download .nbib Format: NLM
Use of enzymes in peptide synthesis.

Applied biochemistry and biotechnology

Chaiken IM, Komoriya A, Ohno M, Widmer F.
PMID: 24234364
Appl Biochem Biotechnol. 1982 Sep;7(5):385-99. doi: 10.1007/BF02798320.

Recent experiments in several laboratories have emphasized the benefits of proteolytic enzymes as effective catalysts for the formation of peptide bonds for synthesis and semisynthesis. This review summarizes successful applications in both stepwise synthesis for small peptides and fragment...

Cite
Chaiken IM, Komoriya A, Ohno M, et al. Use of enzymes in peptide synthesis. Appl Biochem Biotechnol. 1982;7(5):385-99doi: 10.1007/BF02798320.
Chaiken, I. M., Komoriya, A., Ohno, M., & Widmer, F. (1982). Use of enzymes in peptide synthesis. Applied biochemistry and biotechnology, 7(5), 385-99. https://doi.org/10.1007/BF02798320
Chaiken, I M, et al. "Use of enzymes in peptide synthesis." Applied biochemistry and biotechnology vol. 7,5 (1982): 385-99. doi: https://doi.org/10.1007/BF02798320
Chaiken IM, Komoriya A, Ohno M, Widmer F. Use of enzymes in peptide synthesis. Appl Biochem Biotechnol. 1982 Sep;7(5):385-99. doi: 10.1007/BF02798320. PMID: 24234364.
Copy Download .nbib Format: NLM
[Less is more--less is nothing].

Revue medicale suisse

Widmer D.
PMID: 26672185
Rev Med Suisse. 2015 Oct 28;11(492):2038-9.

No abstract available.

Cite
Widmer D. Less is more--less is nothing. [Less is more--less is nothing]. Rev Med Suisse. 2015;11(492):2038-9
Widmer, D. (2015). Less is more--less is nothing. [Less is more--less is nothing]. Revue medicale suisse, 11(492), 2038-9.
Widmer, Daniel. "Less is more--less is nothing." [Less is more--less is nothing]. Revue medicale suisse vol. 11,492 (2015): 2038-9.
Widmer D. Less is more--less is nothing. [Less is more--less is nothing]. Rev Med Suisse. 2015 Oct 28;11(492):2038-9. French. PMID: 26672185.
Copy Download .nbib Format: NLM
Back to the Future of Soil Metagenomics.

Frontiers in microbiology

Nesme J, Achouak W, Agathos SN, Bailey M, Baldrian P, Brunel D, Frostegård Å, Heulin T, Jansson JK, Jurkevitch E, Kruus KL, Kowalchuk GA, Lagares A, Lappin-Scott HM, Lemanceau P, Le Paslier D, Mandic-Mulec I, Murrell JC, Myrold DD, Nalin R, Nannipieri P, Neufeld JD, O'Gara F, Parnell JJ, Pühler A, Pylro V, Ramos JL, Roesch LF, Schloter M, Schleper C, Sczyrba A, Sessitsch A, Sjöling S, Sørensen J, Sørensen SJ, Tebbe CC, Topp E, Tsiamis G, van Elsas JD, van Keulen G, Widmer F, Wagner M, Zhang T, Zhang X, Zhao L, Zhu YG, Vogel TM, Simonet P.
PMID: 26903960
Front Microbiol. 2016 Feb 10;7:73. doi: 10.3389/fmicb.2016.00073. eCollection 2016.

No abstract available.

Cite
Nesme J, Achouak W, Agathos SN, et al. Back to the Future of Soil Metagenomics. Front Microbiol. 2016;7:73doi: 10.3389/fmicb.2016.00073.
Nesme, J., Achouak, W., Agathos, S. N., Bailey, M., Baldrian, P., Brunel, D., Frostegård, �. �., Heulin, T., Jansson, J. K., Jurkevitch, E., Kruus, K. L., Kowalchuk, G. A., Lagares, A., Lappin-Scott, H. M., Lemanceau, P., Le Paslier, D., Mandic-Mulec, I., Murrell, J. C., Myrold, D. D., Nalin, R., Nannipieri, P., Neufeld, J. D., O'Gara, F., Parnell, J. J., Pühler, A., Pylro, V., Ramos, J. L., Roesch, L. F., Schloter, M., Schleper, C., Sczyrba, A., Sessitsch, A., Sjöling, S., Sørensen, J., Sørensen, S. J., Tebbe, C. C., Topp, E., Tsiamis, G., van Elsas, J. D., van Keulen, G., Widmer, F., Wagner, M., Zhang, T., Zhang, X., Zhao, L., Zhu, Y. G., Vogel, T. M., & Simonet, P. (2016). Back to the Future of Soil Metagenomics. Frontiers in microbiology, 773. https://doi.org/10.3389/fmicb.2016.00073
Nesme, Joseph, et al. "Back to the Future of Soil Metagenomics." Frontiers in microbiology vol. 7 (2016): 73. doi: https://doi.org/10.3389/fmicb.2016.00073
Nesme J, Achouak W, Agathos SN, Bailey M, Baldrian P, Brunel D, Frostegård Å, Heulin T, Jansson JK, Jurkevitch E, Kruus KL, Kowalchuk GA, Lagares A, Lappin-Scott HM, Lemanceau P, Le Paslier D, Mandic-Mulec I, Murrell JC, Myrold DD, Nalin R, Nannipieri P, Neufeld JD, O'Gara F, Parnell JJ, Pühler A, Pylro V, Ramos JL, Roesch LF, Schloter M, Schleper C, Sczyrba A, Sessitsch A, Sjöling S, Sørensen J, Sørensen SJ, Tebbe CC, Topp E, Tsiamis G, van Elsas JD, van Keulen G, Widmer F, Wagner M, Zhang T, Zhang X, Zhao L, Zhu YG, Vogel TM, Simonet P. Back to the Future of Soil Metagenomics. Front Microbiol. 2016 Feb 10;7:73. doi: 10.3389/fmicb.2016.00073. eCollection 2016. PMID: 26903960; PMCID: PMC4748112.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 458 entries